Related Experiment Video
Updated: Jun 25, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Developing Best Practice for Analyzing Individual Patient Utility Data in Health Technology Assessment: A Modified
Frank Grimsey Jones1, Alan Lovell1, Saul Stevens1
1Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, England, UK.
Objectives:
Accurate health utilities are critical for health economic models because quality-adjusted life-years combine health utilities and life-years. Individual patient utility data are an important source of these inputs because they are used to calculate health-state utility values; yet, no dedicated best practice guidance exists for analyzing patient-level utility data. This research aimed to develop guidance for analyzing such data and identify gaps.
Methods:
We conducted a scoping survey, literature and National Institute for Health and Care Excellence technology appraisal reviews, and a modified Delphi process to generate consensus-based recommendations. The research examined key analysis considerations including utility distributions (eg, upper bounded), data characteristics (eg, missing data, repeated collection), and associated analytical methods (eg, regression models). It also examined post-hoc adjustments required to address specific data properties. The derivation of individual patient utility data was out of scope.
Results:
Thirty-one participants-predominantly health economists, alongside statisticians-from academia, industry, consultancies, and National Institute for Health and Care Excellence contributed to the Delphi process. Thirteen topics were discussed, covering 3 stages of analysis: core methods, potential adjustments, and sensitivity analyses. Although no new recommendations emerged, the panel refined wording, added clarifications, and expanded recommendations. Broad consensus across all recommendations was achieved by the end of round 3.
Conclusion:
The research informed the development of best practice guidance for analyzing individual patient utility data. Important evidence gaps remain in the published literature, particularly regarding optimal methods for responding to data characteristics. These findings support health technology assessment agencies in providing clearer, more consistent instructions for robust and transparent analysis of these data.
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Bioavailability Study Design: Healthy Subjects Versus Patients
Measurement of Bioavailability: Pharmacodynamic Methods
Dosage Regimen: Individualization
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...